These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Microbiota, Immune System and Autism Spectrum Disorders: An Integrative Model towards Novel Treatment Options. Carpita B; Marazziti D; Palego L; Giannaccini G; Betti L; Dell'Osso L Curr Med Chem; 2020; 27(31):5119-5136. PubMed ID: 31448708 [TBL] [Abstract][Full Text] [Related]
24. Long term beneficial effect of neurotrophic factors-secreting mesenchymal stem cells transplantation in the BTBR mouse model of autism. Perets N; Segal-Gavish H; Gothelf Y; Barzilay R; Barhum Y; Abramov N; Hertz S; Morozov D; London M; Offen D Behav Brain Res; 2017 Jul; 331():254-260. PubMed ID: 28392323 [TBL] [Abstract][Full Text] [Related]
25. Immunological and autoimmune considerations of Autism Spectrum Disorders. Gesundheit B; Rosenzweig JP; Naor D; Lerer B; Zachor DA; Procházka V; Melamed M; Kristt DA; Steinberg A; Shulman C; Hwang P; Koren G; Walfisch A; Passweg JR; Snowden JA; Tamouza R; Leboyer M; Farge-Bancel D; Ashwood P J Autoimmun; 2013 Aug; 44():1-7. PubMed ID: 23867105 [TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stem cells in autism spectrum and neurodevelopmental disorders: pitfalls and potential promises. Simberlund J; Ferretti CJ; Hollander E World J Biol Psychiatry; 2015 Sep; 16(6):368-375. PubMed ID: 26230216 [TBL] [Abstract][Full Text] [Related]
27. Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions. Lacivita E; Perrone R; Margari L; Leopoldo M J Med Chem; 2017 Nov; 60(22):9114-9141. PubMed ID: 29039668 [TBL] [Abstract][Full Text] [Related]
28. A pilot study of high-dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation. Melamed IR; Heffron M; Testori A; Lipe K Autism Res; 2018 Mar; 11(3):421-433. PubMed ID: 29427532 [TBL] [Abstract][Full Text] [Related]
29. [Epigenetics' implication in autism spectrum disorders: A review]. Hamza M; Halayem S; Mrad R; Bourgou S; Charfi F; Belhadj A Encephale; 2017 Aug; 43(4):374-381. PubMed ID: 27692350 [TBL] [Abstract][Full Text] [Related]
30. Evidence supporting an altered immune response in ASD. Mead J; Ashwood P Immunol Lett; 2015 Jan; 163(1):49-55. PubMed ID: 25448709 [TBL] [Abstract][Full Text] [Related]
34. Oxidative Stress and Immune System Dysfunction in Autism Spectrum Disorders. Pangrazzi L; Balasco L; Bozzi Y Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384730 [TBL] [Abstract][Full Text] [Related]
35. Modeling Inflammation in Autism Spectrum Disorders Using Stem Cells. Freitas BC; Mei A; Mendes APD; Beltrão-Braga PCB; Marchetto MC Front Pediatr; 2018; 6():394. PubMed ID: 30619789 [TBL] [Abstract][Full Text] [Related]
36. Neuroimmune Alterations in Autism: A Translational Analysis Focusing on the Animal Model of Autism Induced by Prenatal Exposure to Valproic Acid. Deckmann I; Schwingel GB; Fontes-Dutra M; Bambini-Junior V; Gottfried C Neuroimmunomodulation; 2018; 25(5-6):285-299. PubMed ID: 30157484 [TBL] [Abstract][Full Text] [Related]
37. Review of Clinical Studies Targeting Inflammatory Pathways for Individuals With Autism. Hafizi S; Tabatabaei D; Lai MC Front Psychiatry; 2019; 10():849. PubMed ID: 31824351 [TBL] [Abstract][Full Text] [Related]
38. The Gut-Immune-Brain Axis in Autism Spectrum Disorders; A Focus on Amino Acids. van Sadelhoff JHJ; Perez Pardo P; Wu J; Garssen J; van Bergenhenegouwen J; Hogenkamp A; Hartog A; Kraneveld AD Front Endocrinol (Lausanne); 2019; 10():247. PubMed ID: 31057483 [TBL] [Abstract][Full Text] [Related]
39. Cell Therapy Targets for Autism Spectrum Disorders: Hopes, Challenges and Future Directions. Larijani B; Foroughi Heravani N; Alavi-Moghadam S; Goodarzi P; Rezaei-Tavirani M; Payab M; Gholami M; Razi F; Arjmand B Adv Exp Med Biol; 2021; 1341():107-124. PubMed ID: 32072476 [TBL] [Abstract][Full Text] [Related]